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Summary.-Changes in the immune competence and levels of suppressor elements
were assessed by mitogen stimulation and in vitroantibodyproduction, afterresection
of a transplantable sarcoma. Spleen cells from tumour-resected animals were found
to have depressed responses to conA as well as to the antigens SRBC and DNP-LPS.
This inability to respond was gradually overcome and, by Day 21 after resection,
spleen cell competence had returned to normal levels. Suppressor cells isolated from
the spleens of tumour-resected animals were capable of suppressing the conA
response and PFC response of normal syngeneic spleen cells in vitro. The ability to
suppress the conA response of normal cells disappeared by Day 1 after resection,
while the ability to suppress the anti-SRBC and anti-DNP PFC response of normal
cells disappeared by Day 8 and Day 14 respectively. Serum from tumour-resected
mice was also found to be suppressive to the conA response of normal spleen cells.
The inhibitory material responsible for suppression eluted with the Ig-containing
fraction on Sephadex G-150. This inhibitory material gradually disappeared from the
serum of tumour-resected mice and was no longer apparent by Day 14. Therefore, it
appeared that the return of normal lymphocyte function after tumour-resection was
concomitant with the disappearance of splenic suppressor cells and suppressive
serum factor.
PROGRESSIVE tumour growth in humans
and laboratory animals is frequently
coincident with progressive immunosup-
pression. Tumour-specific immune re-
sponses which develop during early tumour
growth decline and often disappear en-
tirely (Deckers et al., 1973; Howell,
Esber and Law, 1974; Youn, LeFrancois
and Barski, 1973; Whitney, Levy and
Smith, 1974). General immune responses,
such as delayed hypersensitivity reactions
to recall antigens and in vitro lymphocyte
stimulation by mitogens and antigens,
are also depressed in many cancer patients
(Krant et al., 1968; Golub, O'Connell and
Morton, 1974). Similarly, the response of
mouse spleen cells to both mitogens and
specific antigens declines with increasing
tumour size (Adler, Takiguchi and Smith,
1971; Rowland et al., 1973). At present
many immunological functions have been
suggested to be involved in tumourgrowth.
Recent theories have suggested that
tumours grow progressively because of the
presence of blocking factors, particularly
blocking antibodies or antigen-antibody
complexes (Baldwin, Price and Robins,
1973; Hellstr6m and Hellstrom, 1970;
Gorczynski et al., 1974); because of a
defect in the host's immune response,
both cellular and humoral; or because of
suppressor elements that develop con-
currently with tumourgrowth and actively
antagonize the host's response to tumours
and other antigens (Kirchner et al., 1974;
Whitney and Levy, 1974; Waldmann
and Broder, 1977).
Numerous time-course experiments
describing the development of cell-
mediated immunity in tumour-bearing
hosts have shown that an "eclipse" of
tumour-specific immunity occurs after
the tumour reaches a certain critical size.
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logically responsive state followed surgical
removal of the tumour (LeFrancois et al.,
1971; Heppner, 1972). Other work has
shown that non-specifically depressed cell-
mediated immunity in tumour-bearing
hosts could be restored to normal levels
aftersurgicalresection (Gillette andBoone,
1975; Adler et al., 1971). Loss of serum-
blocking activity in tumour-bearing hosts
following surgical removal of the tumour
has also been well documented (Bray and
Keast, 1975; Bray and Holt, 1975).
Previous studies in our laboratory have
shown that the decrease in lymphocyte
competence that occurs with progressive
tumour growth was concomitant with the
appearance of an immuno-suppressive
serum factor which inhibited lymphocyte
proliferation. This suppressive factor sepa-
rated with the 7S immunoglobulins on
Sephadex G150 and G-200, and could be
removed by absorption on anti-mouse-Ig
columns (Whitney and Levy, 1975; Levy
et al., 1976). It was also shown that mice
with tumours developed suppressor cells
in their spleens which inhibited mitogen
responses of normal lymphocytes just
as the serum factor did. Treatment of the
suppressor spleen population with anti-0
or anti-Ig and complement did not
remove the suppressor cells. In contrast,
treatments which remove adherent cells,
including passage through nylon wool
columns and treatment with carbonyl
iron, effectively removed the suppressor
activity. It was concluded that the
suppressor cell was of the macrophage/
monocyte series (Pope et at., 1976).
The present study was undertaken to
follow the restoration of normal lympho-
cyte function after resection of solid
tumours from DBA/2J mice. Recovery of
normal function was correlated with the
disappearance of the suppressive serum
factor and splenic suppressor cells.
MATERIALS AND METHODS
Experimental animals
DBA/2J female mice (Jackson Laboratory,
Bar Harbor, Maine) aged 8-10 weeks were
used in all experiments.
Tumour
Thetumour used was a methycholanthrene-
induced rhabdomyosarcoma (M-1) obtained
originally from the Jackson Laboratory, and
maintained both in vivo and in vitro in this
laboratory for the past 4 years. Methods for
the maintenance and culture of the tumour
have been described elsewhere (Whitney etal.,
1974). Animals were injected with 2 x 104
viable M-1 cells and palpable tumours were
observed 7-10 days later. Once palpable,
the tumours grew uniformly. The tumour was
grown s.c. on the animal's right abdominal
side, thus allowing easy surgical resection.
Surgical resection
Resections were carried out 32 days after
tumour implantation. At this time, the
tumour mass was 3-5-4-5 g. The animals were
partially anaesthetized by i.p. injection
of sodium pentobarbital (Nembutal-Abbott
Laboratories, Montreal, Canada; 0-75 mg per
animal) and were maintained under ether
anaesthesia during surgical removal of the
tumours. Previous studies in this laboratory
had shown that surgical resection of small
tumours, from mice in which immune com-
petence had not yet become impaired, did not
cause any changeofimmunestatusinresected
animals in comparison to untreated controls
(Levy et at., 1974). Other studies had shown
that sham-operated animals did not have
suppressive factors in their serum (un-
published data). For these reasons, untreated
normal animals were used in this study rather
than sham-operated controls.
Preparation oflymphoid cell suspensions
Normal and tumour-resected animal's
spleens were removed aseptically, and cell
suspensions were prepared by pressing them
through stainless steel screens into phosphate-
buffered saline (PBS), containing 5% foetal
calf serum (FCS). The cells were centrifuged
and resuspended in 10 ml of 0.83% NH4Cl
for 3-4 min to remove erythrocytes, followed
by centrifugation and one further wash with
PBS. The cells were then counted by the
trypan blue exclusion method.
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Assays for immune competence
Mitogen stimulation.-Spleen cells were
cultured in microtitre plates as has been
previously described, with gentamycin
(50 ,tg/ml) being the only antibiotic (Whitney
et al., 1974). The mitogen concanavalin A
(conA) was used at a final concentration of
4 ,ug/ml. When testing for competence, the
various cell populations were tested sepa-
rately at 5 x 105 cells/well. When testing for
suppressor cell activity 5 x 105 normal
spleen cells were cultured with 3 x 105
tumour-resected animal's spleen cells. After
2 days in culture, 3H-thymidine was added
(1 MuCi/well, sp. act. 2 Ci/mmol, Amersham/
Searle, Don Mills, Ontario) and the cultures
were harvested 18 h later, as previously
described (Whitney and Levy, 1974).
In vitro antibody production
Spleen cells from normal and tumour-
resected mice were cultured at 106 and 2 x 106
per microtitre plate containing 0-25 ml
RPMI-1640 medium supplemented with 10%
FCS (Flow Laboratories, Lot No. 40551044)
and 5 x 10-5 M 2-mercaptoethanol. Antigens
used were either 2-5 x 106 SRBC/ml or
0-1 jug/ml DNP-LPS, the latter of which
behaves in vitro as a T-cell-independent
antigen. The DNP-LPS was prepared accord-
ing to Jacobs and Morrison (1975). Cultures
were incubated at 37°C on a rocking platform.
The DNP-LPS cultures were incubated for
3 days and the SRBC cultures for 4 days, as
preliminary assays had shown these to be the
optimal times for detection ofplaque-forming
cells (PFC). The number of direct PFC was
determined with a microscope-slide assay
described previously (Cunningham and
Szenberg, 1968). DNP plaques were deter-
mined using SRBC coated with dinitro-
phenylated rabbit anti-SRBC-Fab' (Straus-
bauch, Sulica and Givol, 1970). Specific
anti-DNP plaques were enumerated by
substracting background SRBC plaques from
the total number obtained. When testing
for competence, normal and tumour-resected
animal's spleen cells were cultured separately
at 106 cells/well. When testing for suppressor
activity, 106 normal spleen cells were cultured
with 106 tumour-resected animal's spleen
cells. The viability of all cultures are about
the same (36-48%). All results are expressed
as PFC/well.
Collection and preparation of serum
Blood was taken from both normal and
tumour-resected animals by exsanguination
from the heart. It was allowed to clot over-
night at 4°C, after which the serum was
removed, centrifuged to remove residual
erythrocytes, inactivated at 56°C for 30 min
and stored at -20°C.
All work reported herein was carried out on
the immunoglobulin-rich fraction of sera
from a Sephadex G-150 column. Detailed
procedures for this fractionation have been
published previously (Levy et al., 1976).
Assayfor inhibitory serumfactor
Mitogen stimulation.-Sera were assayed as
previously described (Whitney et al., 1974;
Whitney and Levy, 1974, 1975). In brief,
5 x 105 normal spleen cells were cultured in
0-20 ml of RPMI-1640 medium supplemented
with 2.5% FCS in microtitre plates with
200 Hug/ml of test material from either normal
or tumour-resected animal's serum. ConA
was added in a volume of 0 05 ml at a con-
centration of 1 jug/ml. The cultures were
incubated for 48 h, after which 1 ,tCi of
3H-TdR was added. Cultures were harvested
and 3H-TdR incorporation was measured
18 h later. Values achieved by cultures at
equivalent quantities of normal mouse serum
were taken as the 100% level, and percentage
inhibition was calculated by comparing the
uptake values of samples containing equiva-
lent quantities of tumour-resected animal's
serum to the 100% value, according to the
formula:
0 inhibition
ConA response in cultures with NFI -
ConA response in cultures with TF1
ConA response in cultures with NFl x 100
where NFI fractionated serum from nor-
mal mice, and
TFI fractionated serum from
tumour-resected mice.
Data presentation
Where appropriate, results are expressed
as the mean value ± s.d. The statistical
significance of differences in mean values
was determined by Student's t test. Differen-
ces were considered significant if the prob-
ability that the observed difference occurring
by chance alone was <500 (i.e. P<0 05). All
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data represent results from typical experi-
ments.
RESULTS
Immune competence of tumour-resected
animals
The general immunological status of
normal and tumour-resected animal's
spleen cells was determined at various
times after surgical resection. In vitro
stimulation with conA was used to assess
T-cell competence while in vitro antibody
production to SRBC and DNP-LPS was
used as a measure of B-cell competence.
Table I demonstrates that statistically
significant differences in T-cell response
between normal and tumour-resected
animal's spleen cells were found during
the first 4 days after surgical resection,
while complete recovery was apparent
by Day 14. From Tables II and III it is
evident that B-cell competence in tumour-
resected animals is also depressed, as
shown by a decreased ability to respond to
SRBC, a T-dependent antigen, and DNP-
LPS, a T-independent antigen. Both
tables show that after surgical resection
there is a progressive rise in the non-
specificallydepressedB-cell response ofthe
tumour-resected animals, with complete
recovery evident by Day 21.
Suppression by tumour-resected animal's
spleen cells
When spleen cells from the Day 0
tumour-resected animals were mixed with
normal spleen cells, the ability of the
normal cells to respond to conA was
suppressed (Table IV). This finding is in
agreement with previous studies (Pope
TABLE I.-ConA Responses of Mice at Various Times after Tumour Resection
Spleen cell source*
Normal
Tumour-resected animals
r 0
Days I
after 4
re-section | 14
21
3H-TdR incorporationt
No conA ConA
4900 i 1020 125000 ± 24000
8100 ± 1430
8530 ± 1170
10500 ± 2460
13200 ± 4710
11400 ± 1320
10300 ± 2640
54400 : 7800
55500 ± 4810
53900 ± 11000
98300 ± 15000
127000 ± 18200
124000 ± 7100
<0-001
<0-001
<0*001
N.S.
N.S.
N.S.
* Cultures consisted of 5 x 105 normal or tumour-resected animal's spleen cells.
t Results are expressed as the mean ct/min ± s.d. Individual groups consisted of at least 6 animals. t Using Student's t test. N.S.: not significant.
TABLE II.-Recovery ofImmunological Competence after
Tumour Resection as Assessed by the Anti-SRBC Response in vitro
Days from Spleen cell
resection source*
0
1
4
8
14
21
N
TR
N
TR
N
TR
N
TR
N
TR
N
TR
PFC/wellt
873 ± 63
235 ± 35
935 ± 87
230 + 35
565 ± 32
218 ± 44
832 ± 57
607 ± 54
775 ± 47
646 ± 65
630 ± 62
641 ± 49
Pt
<0-001
<0-001
<0-001
<0-01
<005
N.S.
* Cultures consisted of 106 normal (N) or tumour-resected (TR) animal's spleen cells.
t Mean ± s.d. 3 animals per group.
$ Using Student's t test.
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TABLE III.-Recovery of Immunological Competence after
Tumour Resection as Assessed by the Anti-DNP Response in vitro
Days from
resection
0
1
4
8
14
21
Spleen cell
source*
N
TR
N
TR
N
TR
N
TR
N
TR
N
TR
PFC/wellt
484 ± 58
113 ± 14
465 ± 49
147 4- 28
359 4 47
202 ± 22
416 + 46
245 ± 33
411 ± 52
278 + 31
412 -1- 40
407 i 51
P+
<0-001
<0-001
<0-01
<0-01
<0-02
N.S.
* Cultures consistedi of 106 normal (N) or tumour-resected (TR) animal's spleen cells.
t Mean - s.d. 3 animals per grou).
I Using Student's t test.
TABLE IV. Assayfor Suppressor Cells in Mice after Tumour Resection
Spleein cell
souirce
Normal (5 x 105)
Normal (8 x 105)
Normal (5 x 105)
resected (3 x 10a)*
+tumour
r 0
Days |
from 4
resection 8
L 4
3H-TdR incorporationt
No ConA
4900 ± 1020
8980 - 2360
12300 31 3210
13600 ± 2960
10200 ± 2430
13200 ± 4260
12600 + 3080
12100 ± 2290
ConA
125000 ± 24000
143000 ± 18800
87000 ± 14300
115000 ± 15500
124000 ± 8450
122000 ± 11900
141000 ± 16800
149000 + 8000
Pt
<0-01
N.S.
N.S.
N.S.
N.S.
N.S.
* Cells from resectedl animals were mixed with normal cells and incubated.
t Mean ct/min ± s.d. At least 6 animals per group. I Test cultures were compare(d to the normal control culture containing 5 x 105cells. Statistical significance calculated using Student's t test.
et al., 1976). In those animals tested during
the post-surgical period for suppression
of the conA response, a significant level of
suppressor spleen cells was not detected.
However, Fig. 1 demonstrates the pre-
sence of splenic suppressor cells capable
of suppressing the in vitro antibody
response to SRBC. A significant level of
suppressor cells was found during the
first 4 days after resection, but dis-
appeared by Day 8. By Day 21, the
response of the mixture of normal and
tumour-resected animal's spleen cells had
essentially returned to normal. Fig. 2
demonstrates suppression of the in vitro
anti-DNP antibody response. Significant
suppression was detected during the first
8 days after surgery. By Day 14, the
suppressor cell activity was no longer
detectable.
It is important to note that in all cases
a conservative approach to calculating sup-
pression was used. A response was called
suppressed when it was found that the
addition of tumour-resected animal's
spleen cells to a culture of normal spleen
cells lowered the response, whereas adding
normal spleen cells to the culture raised
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4)
3.
u-u
CL
Days Following Resection
FiG. 1.-Assay for suppressor cells in ttliotr-iesecte(d animials. 'he nuimber of anti-SRBCI)laqlIes/ xv-ell Of 106 inoirm18al cells (E), 2 < 106 niormal cells ( -) aIi(I 106 nornal cells p1is 1 06 tuinour- resecte(1 cells (in) are conpare(l. P for suippressiol relates to comparison of the test culture with the normalcellctlture of 106ce11s.
the response. An example of this is
clearly shown in Fig. 1, where during the
first 4 days after resection, the addition of
106 tumour-resected animal's spleen cells
to 106 normal spleen cells lowered the
PFC response to SRBC below that of 106
normal spleen cells alone.
Inhibitory effects of fractionated sera from
tumour-resected animals
Serum from normal and tumour-re-
sected mice was fractionated on Sephadex
G-150, and the Ig-cointaining fraction was
tested for its inhibitory activity by adding
it to cultures of normal mouse spleen
cells stimulated with conA. All serum
samples were tested at 200 jtg protein/ml.
The data are shown in Table V. As has
been previously noted (Levy et al., 1976),
serum fraction 1 from normal mice was
also somewhat inhibitory. The serum
fractions were not cytotoxic, as the cell
recovery from the experiment was com-
parable to cultures with only culture
medium.
Serum from tumour-resected animals
during the first 8 days was significantly
inhibitory to the conA response of normal
mouse spleen cells. By Day 14 this effect
was no longer apparent.
DISCUSSION
A large amount of work has been done
to show that after surgical resection there
is a return of lymphocyte competence, as
measured by a return of anti-tumour
immune responses or an increase in the
ability of spleen cells to respond to
mitogens (Gillette and Boone, 1975; Whitney et al., 1974; Barski and Youn,
1969; Heppner, 1972). Very little work
has been done to show the effects of
resection on the fate ofsuppressor elements
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t4)
Days Following Resection
Fie(. 2.- Assay forsuppressor cells ini tumour-resectetl aniiials. The nurnber of anti-D)NP )laqules/ well of: 106 normal cells (u), 2 x 106 normal cells (O) an(i 106 niormal cells pluIs; 106 tutmouir- resecte(l cells (ED) are compare(l. P for suppression relates tocomp)arison of the test culture with the
normal cell cultture of 106 cells.
TABLE V.-Assayfor a Suppressive Serum Factorfrom Mice after Tumour Resection
Serum source*
None
Normal
Tumour-resected animals
r 0
Days I
from I4
resection 8
L21
3H-TdR incorporationt
with ConA
68200 ± 9630
36500 ± 1700
18800 i 1790
22600 + 2020
25200 ± 1640
26500 ± 4660
34100 ± 5390
38400 ± 3740
%0
inhibition
48
38
31
27
7
-5
<0-001
<0-001
<0-01
<0-05
N.S.
N.S.
* The Ig-rich Sephadex G-150 fraction of test or normal mouse serum was a(lded at 200 )ug/ml to cultures of normal mouse lymphocytes.
t Mean ct/min + s.d. 3 animals per group. I By comparing the stimulation oftest cultures with ones containing equivalent conicentrations of normal mouse Ig.
§ Using Student's t test.
in tumour-bearing hosts. This report
clearly shows that after tumour resection
there is a gradual disappearance of
suppressor cells and suppressive serum
factor, and this occurs concurrently with
an increase in lymphocyte competence.
Tumours were resected from animals
in which immune competence, as assessedRECOVERY OF IMMUNE COMPETENCE AFTER TUMOUR RESECTION
by a variety of parameters, was severely
depressed. The recovery of immune com-
petence after resection was followed by
measuring, over a period of 21 days, the
animal's ability to respond to the T-cell
mitogen conA, and to respond with the
development of plaque-forming cells to
SRBC and DNP-LPS. The results are
quite clear. Within 8 days, conA responses
are normal, whereas significantly lower
levels of both anti-SRBC and anti-DNP
plaques were observed up to Day 14 after
resection. It is probable that this differ-
ence reflects differences in the sensitivity
of the assays rather than anything unique
about B-cell recovery as opposed to T-cell
recovery.
We have shown previously that the
spleens of mice bearing large M-1 tumours
contained non-specific suppressor cells
which could suppress both B- and T-cell-
mitogen responses of normal syngeneic
lymphocytes (Pope et al., 1976). In these
studies, the presence of these cells in
animals after resection was assessed
both by the mitogen assay previously
described and by their ability to suppress
both T-cell-dependent and T-cell-indepen-
dent B-cell responses of normal syngeneic
splenocytes in vitro. This assay involved
mixing 106 normal spleen cells with 106
spleen cells from resected animals before
incubation with antigen. These were run
concurrently with cultures of normal
splenocytes at 106 and 2 x 106/well.
Cultures containing 2 x 106 cells in-
variably produced higher numbers of
PFC. However, suppression is measured
by comparing the number of PFC in
cultures of 106 normal cells with cultures
of 106 normal plus 106 resected-animal's
cells. The assumption is made that the
resected-animal's cells are non-responsive
and therefore contribute nothing. This is a
very conservative method for assessing
suppression, but we decided that this was
preferable to applying a formula to predict
theoretical numbers of plaques in the
mixed cultures. Using this conservative
assay, it can be seen that significant
suppression ofthe anti-SRBC response was
observable through Day 4, while sup-
pression of the anti-DNP response was
observed through Day 8. No significant
differences in the amount or duration of
suppression between the T-cell-dependent
and independent responses were noted.
The conA assay for suppression, in which
5 X 105 normal cells are mixed with
3 x 105 resected-animal's cells, showed
significant suppression only on the day of
surgery. Again, this difference, rather
than indicating any basic differences in
suppressor cell populations, probably indi-
cates differences in the sensitivity of the
assays.
We observed some time ago that the
serum of tumour-bearing animals was
suppressive to a number of immuno-
logical reactions of normal lymphoid
cells, and that this suppressive factor
resided in the immunoglobin fraction of
serum when it is subjected to Sephadex
G-150 gel filtration (Levy et al., 1976;
McMaster et al., 1977). The rate at which
this suppressive material disappeared from
the serum ofresected animals was assessed
by titrating the Ig-rich fraction of experi-
mental animal's serum with normal
lymphoid cells in the presence of conA.
The results showed that significant sup-
pression was observable through Day 8
after resection. Even though it might
appear that there is a direct link between
the suppressor cells and the serum factor,
because significant suppression by both
mechanisms is present for about 8 days
after resection, it should be pointed out
that this is not necessarily the case. In a
previous study (Whitney, Pope and Levy,
1977) it was found that splenectomized
animals with tumours did not develop
suppressor cells in their lymph nodes, but
did have the suppressive serum factor at
levels comparable to intact animals.
It thus appears that recovery of immu-
nological competence in tumour-resected
animals takes about 14 days from surgical
removal of the tumour load. The dis-
appearance of non-specific suppressor cells
and the suppressive serum factor correlate
positively with this, in that they can
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both be assayed for up to 8 days after
resection. The cause and effect of this
phenomenon are not yet understood, but
the presence of an excessive antigen load
in the form of tumour cells may be the
primary effector.
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